Showing 1 - 20 results of 29 for search '"This Week in Virology"', query time: 1.86s Refine Results
  1. 1
    Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.
    Get full text
    Article
  2. 2
    Using ASM Podcasts to Excite Undergraduate Students about Current Microbiological Research
    by Stacey E. Lettini
    Published 2014-08-01
    “... (TWiP), and This Week in Virology (TWiV). These podcasts are usually presented in a manner similar to a...”
    Get full text
    Article
  3. 3
    CSV2018: The 2nd Symposium of the Canadian Society for Virology
    by Nathalie Grandvaux, Craig McCormick
    Published 2019-01-01
    “... public engagement with female scientists, and the live-taping of the 499th episode of the This Week...”
    Get full text
    Article
  4. 4
    Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
    “... additional 48 weeks. High virological and immunological  effectiveness maintained during the study...”
    Get full text
    Article
  5. 5
    Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
    “... genotyped. Early virological response (EVR) (12 weeks), end-of-treatment response (EOTR) (48 weeks...”
    Get full text
    Article
  6. 6
    Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
    “... genotyped. Early virological response (EVR) (12 weeks), end-of-treatment response (EOTR) (48 weeks...”
    Get full text
    Article
  7. 7
    Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
    “... patients were treated with a 300-mg once-daily dose of TDF for more than 12 weeks. Virological markers...”
    Get full text
    Article
  8. 8
    Pre-Antiretroviral Therapy Serum Selenium Concentrations Predict WHO Stages 3, 4 or Death but not Virologic Failure Post-Antiretroviral Therapy
    “... (incident World Health Organization (WHO) stage 3, 4 or death by 96 weeks) or virologic failure by 24...”
    Get full text
    Article
  9. 9
    Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1.
    “... asunaprevir (200 mg/day) was given for 24 weeks. The virological responses and resistance-associated...”
    Get full text
    Article
  10. 10
    HIV-1 tropism and CD4 T lymphocyte recovery in a prospective cohort of patients initiating HAART in Ribeirão Preto, Brazil
    “... weeks. Similar virological and immunological responses were observed for both treatment regimens. The 43...”
    Get full text
    Article
  11. 11
    Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan
    “... at least 4-week medication. Virologic failure was recorded as breakthrough, nonresponse, or relapse. Safety...”
    Get full text
    Article
  12. 12
    The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
    “... patients with HCV GT2 with/without cirrhosis were treated with SOF/RBV for 16/12 weeks. Rapid virological...”
    Get full text
    Article
  13. 13
    Early Experience of Sofosbuvir based Combination Therapy in “Real-Life” Cohort with Chronic Hepatitis-C Infection
    “... regimen (SOF and RBV) for either 12 or 24 weeks. The virological responses were obtained at baseline...”
    Get full text
    Article
  14. 14
    Assessment of autoregressive integrated moving average (ARIMA), generalized linear autoregressive moving average (GLARMA), and random forest (RF) time series regression models for predicting influenza A virus frequency in swine in Ontario, Canada.
    “... of sensitivity than the ARIMA and GLARMA models. The number of weekly positive virological submissions...”
    Get full text
    Article
  15. 15
    Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan
    “... terminated treatment early due to adverse events (one at week 4, one at week 46), virological failures (one...”
    Get full text
    Article
  16. 16
    Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C
    by Jung Hwan Yu, Jung Il Lee, Kwan Sik Lee, Ja Kyung Kim
    Published 2017-08-01
    “... response at week 4. Virologic response at end of treatment and sustained virologic response at 12 weeks...”
    Get full text
    Article
  17. 17
    Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study.
    “...-based regimen to a once-daily combination based on ETR maintained undetectable VL during 48 weeks...”
    Get full text
    Article
  18. 18
    Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C
    “... and self-report), side effects and engagement in risk behaviours. Post-treatment visits occur at 12 weeks...”
    Get full text
    Article
  19. 19
    Sofosbuvir‐based therapies in genotype 2 hepatitis C virus cirrhosis: A real‐life experience with focus on ribavirin dose
    “... was 13.9 mg/kg/day, and therapy duration was 16 weeks. Sustained virological response (SVR) rates were 93.8...”
    Get full text
    Article
  20. 20
    Retrospective study of hepatitis c virus relapse after treatment with sofosbuvir and daclatasvir with or without ribavirin
    “...% reported 12-week sustained virologic response (SVR) after treatment for 84 days. The current study goals...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search